Publications by authors named "Gallican Nshogoza Rwibasira"
Article Synopsis
- STIs pose a significant global health challenge, and in Rwanda, there's limited data on their prevalence in the general population from 2014-2020.
- A retrospective analysis of screening data from all health facilities revealed that approximately 5.3 million to 6.7 million individuals were screened for STIs annually, with a notable 45% increase in diagnoses by 2019-2020.
- The prevalence of STI syndromes among screened patients ranged from 2.37% to 4.16%, with urban areas, particularly Kigali city, showing the highest rates, indicating possible improvements in public awareness and data collection methods.
Background: The relationship between HIV infection and COVID-19 clinical outcomes remains a significant public health research problem. We aimed to determine the association of HIV comorbidity with COVID-19 mortality.
Methods: We searched PubMed, Google Scholar and World Health Organization library databases for relevant studies.
Time to complete hepatitis C cascade of care among patients identified during mass screening campaigns in rural Rwanda: a retrospective cohort study.
BMC Infect Dis
March 2022
Article Synopsis
- - The study evaluated the progression of individuals who tested positive for hepatitis C virus (HCV) during a mass screening in rural Rwanda, focusing on how well they moved through the healthcare system from diagnosis to treatment success.
- - Among 666 HCV positive participants, the majority were female (68.1%) with a median age of 61; while most received viral load results, only a little over half achieved sustained virological response (SVR12), which indicates successful treatment.
- - Timely care was a significant issue, with only 66% receiving their initial viral load results within 30 days and a median total time of 437 days from screening to SVR12 assessment, suggesting delays in the treatment process in these low
Despite an array of preventive global public health interventions, SARS-CoV-2 has continued to spread significantly, infecting millions of people across the globe weekly. Newer variants of interest and concern have continued to emerge, placing the need for policymakers to rethink prevention strategies to end the pandemic. The approval of SARS-CoV-2 vaccines for public health use in December 2020 was seen as a significant development towards pandemic control and possibly ending the pandemic.
View Article and Find Full Text PDFHIV incidence and prevalence among adults aged 15-64 years in Rwanda: Results from the Rwanda Population-based HIV Impact Assessment (RPHIA) and District-level Modeling, 2019.
Int J Infect Dis
March 2022
Objectives: The 2018-2019 Rwanda Population-based HIV Impact Assessment (RPHIA) was conducted to measure national HIV incidence and prevalence. District-level estimates were modeled to inform resources allocation.
Methods: RPHIA was a nationally representative cross-sectional household survey.